GLP-1s Prevent Colorectal Cancer: Study Shows Better Results Than Aspirin

GLP-1s Prevent Colorectal Cancer: Study Shows Better Results Than Aspirin

January 6, 2026 Dr. Jennifer Chen Health

here’s ⁣a⁢ breakdown of the references provided, formatted for clarity:

  1. Daily News ASCO Pubs: GLP-1 receptor agonists‌ show potential relative reduction in CRC incidence ⁤compared https://dailynews.ascopubs.org/do/glp-1-receptor-agonists-show-potential-relative-reduction-crc-incidence-compared
  2. Jones C, et al. (2026): GLP-1 receptor agonist vs aspirin for primary prevention ⁤of colorectal cancer: evidence from a real-world head-to-head comparison. Presented at: ASCO Gastrointestinal Cancers Symposium; January 8-10, 2026. ⁣Abstract 18.
  3. American Cancer Society (2025): key statistics for colorectal cancer. Accessed⁤ January 6, 2026. https://www.cancer.org/cancer/types/colon-rectal-cancer/about/key-statistics.html